tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Novo says ‘very likely’ Ozempic part of next U.S. price negotiations

At the Cantor Global Healthcare Conference, Novo Nordisk’s senior vice president of finance and operations, Ulrich Otte, said, “It is very likely that Ozempic will be part of negotiations in the coming round, and we’re ready for that.” The executive was referring to bargaining with the U.S. government over the weight loss drug’s price.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1